Study of Transitioning From Alendronate to Denosumab
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the efficacy and safety of transitioning postmenopausal women on
current alendronate therapy to denosumab. Endpoints studied will include bone mineral
density, bone turnover markers and bone histology in a subset of subjects.